Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/toxins12110721 http://scihub22266oqcxt.onion/10.3390/toxins12110721 33218049!7698915!33218049     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Toxins+(Basel) 2020 ; 12 (11): ä Nephropedia Template TP {{tp|p=33218049|t=2020. Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia |pdf=|usr=}}{{33218049}} gab.com Text Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia JO: Toxins (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=33218049 #FOAvip Pneumonia is an acute pulmonary infection associated with high mortality and an immense financial burden on healthcare systems. Staphylococcus aureus is an opportunistic pathogen capable of inducing S. aureus pneumonia (SAP), with some lineages also showing multidrug resistance. Given the high level of antibiotic resistance, much research has been focused on targeting S. aureus virulence factors, including toxins and biofilm-associated proteins, in an attempt to develop effective SAP therapeutics. Despite several promising leads, many hurdles still remain for S. aureus vaccine research. Here, we review the state-of-the-art SAP therapeutics, highlight their pitfalls, and discuss alternative approaches of potential significance and future perspectives. Twit Text FOAVip Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia ????Toxins (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=33218049 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33218049 #FOAvip English Wikipedia <ref>{{Cite pmid|33218049}}</ref> Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia #MMPMID33218049 Vlaeminck J; Raafat D; Surmann K; Timbermont L; Normann N; Sellman B; van Wamel WJB; Malhotra-Kumar S Toxins (Basel) 2020[Nov]; 12 (11): ä PMID33218049show ga Pneumonia is an acute pulmonary infection associated with high mortality and an immense financial burden on healthcare systems. Staphylococcus aureus is an opportunistic pathogen capable of inducing S. aureus pneumonia (SAP), with some lineages also showing multidrug resistance. Given the high level of antibiotic resistance, much research has been focused on targeting S. aureus virulence factors, including toxins and biofilm-associated proteins, in an attempt to develop effective SAP therapeutics. Despite several promising leads, many hurdles still remain for S. aureus vaccine research. Here, we review the state-of-the-art SAP therapeutics, highlight their pitfalls, and discuss alternative approaches of potential significance and future perspectives. |*Staphylococcus aureus/pathogenicity/physiology[MESH] |*Virulence Factors[MESH] |Animals[MESH] |Bacterial Vaccines/therapeutic use[MESH] |Biofilms[MESH] |Genomics[MESH] |Humans[MESH] |Metabolomics[MESH]Exploring Virulence Factors and Alternative Therapies against Staphylo(epmc).pdf DeepDyve Pubget Overpricing